CL2008003133A1 - Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. - Google Patents
Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa.Info
- Publication number
- CL2008003133A1 CL2008003133A1 CL2008003133A CL2008003133A CL2008003133A1 CL 2008003133 A1 CL2008003133 A1 CL 2008003133A1 CL 2008003133 A CL2008003133 A CL 2008003133A CL 2008003133 A CL2008003133 A CL 2008003133A CL 2008003133 A1 CL2008003133 A1 CL 2008003133A1
- Authority
- CL
- Chile
- Prior art keywords
- drug
- alzheimer
- patients
- preparation
- treatment
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 102000008100 Human Serum Albumin Human genes 0.000 title abstract 2
- 108091006905 Human Serum Albumin Proteins 0.000 title abstract 2
- 208000010877 cognitive disease Diseases 0.000 title abstract 2
- 238000001802 infusion Methods 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
USO DE ALBÚMINA HUMANA PARA LA PREPARACIÓN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE DESÓRDENES COGNITIVOS EN PACIENTES CON ALZHEIMER SIN DEPENDENCIA DEL CONTENIDO DE AB EN SANGRE DEL PACIENTE DONDE EL MEDICAMENTO SE ENCUENTRA EN FORMA DE SOLUCIÓN PARA RECAMBIO PLASMÁTICO Y/O PERFUSIÓN INTRAVENOSA EN QUE LA ALBÚMINA ESTÁ INICIALINENTE A UNA CONCENTRACIÓN COMPRENDIDA ENTRE EL 4% (P/V) Y 25% (P/V).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200702831A ES2332846B1 (es) | 2007-10-26 | 2007-10-26 | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2008003133A1 true CL2008003133A1 (es) | 2009-08-07 |
Family
ID=40583637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2008003133A CL2008003133A1 (es) | 2007-10-26 | 2008-10-23 | Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7851446B2 (es) |
| EP (1) | EP2111868B1 (es) |
| JP (1) | JP5437619B2 (es) |
| CN (1) | CN101417123B (es) |
| AR (1) | AR068901A1 (es) |
| AU (1) | AU2008233025B8 (es) |
| BR (1) | BRPI0804623B8 (es) |
| CA (1) | CA2641830C (es) |
| CL (1) | CL2008003133A1 (es) |
| ES (2) | ES2332846B1 (es) |
| MX (1) | MX2008013635A (es) |
| NZ (1) | NZ572131A (es) |
| PL (1) | PL2111868T3 (es) |
| PT (1) | PT2111868E (es) |
| RU (1) | RU2414925C2 (es) |
| UY (1) | UY31418A1 (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2802628C2 (ru) * | 2018-10-25 | 2023-08-30 | Грифольс Уорлдуайд Оперейшнс Лимитед | Использование плазмафереза малого объема для лечения болезни альцгеймера на ранних и средних стадиях |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5843345B2 (ja) | 2010-07-08 | 2016-01-13 | 旭化成メディカル株式会社 | β−アミロイド除去システム |
| HRP20211628T1 (hr) * | 2016-08-18 | 2022-02-04 | Alkahest, Inc. | Frakcije krvne plazme kao tretman za kongitivne poremećaje povezane sa starenjem |
| US10525107B2 (en) | 2016-08-18 | 2020-01-07 | Alkahest, Inc. | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
| BR112019022402A2 (pt) | 2017-04-26 | 2020-05-19 | Alkahest Inc | regime de dosagem para tratamento de comprometimentos cognitivo e motor com plasma sanguíneo e produtos de plasma sanguíneo |
| US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| WO2020018343A1 (en) * | 2018-07-20 | 2020-01-23 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| EP3643319A1 (en) * | 2018-10-25 | 2020-04-29 | Grifols Worldwide Operations Limited | Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages |
| MX2021004755A (es) | 2018-10-26 | 2021-06-08 | Alkahest Inc | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria. |
| WO2022089639A1 (zh) | 2020-10-30 | 2022-05-05 | 深圳普罗吉医药科技有限公司 | 人血清白蛋白在治疗疾病中的应用 |
| BR112023020972A2 (pt) * | 2021-04-30 | 2023-12-12 | Grifols Worldwide Operations Ltd | Uso de troca de plasma terapêutico e baixo volume de troca de plasma para o tratamento de uma diminuição cognitiva |
| WO2025230830A1 (en) | 2024-04-29 | 2025-11-06 | Alkahest, Inc. | Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3612137A1 (de) * | 1986-04-10 | 1987-10-15 | Biotest Pharma Gmbh | Steriles plasmaaustauschmittel |
| US5112298A (en) | 1990-06-25 | 1992-05-12 | Baxter International Inc. | Apheresis method and device |
| US5178603A (en) | 1990-07-24 | 1993-01-12 | Baxter International, Inc. | Blood extraction and reinfusion flow control system and method |
| US6627151B1 (en) * | 1997-06-13 | 2003-09-30 | Helmut Borberg | Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion |
| JP4851676B2 (ja) | 2000-05-23 | 2012-01-11 | ザ ユニバーシティ オブ サザン カリフォルニア | アルツハイマー病におけるｌｄｌレセプタータンパク質１（ｌｒｐ−１）の役割 |
| EP1370240A4 (en) * | 2001-03-02 | 2004-09-22 | Neuron Therapeutics Inc | NEUROPROTECTOR FORMULATIONS AND METHOD |
| US20050227941A1 (en) | 2001-12-17 | 2005-10-13 | Karen Duff | Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases |
| KR101122782B1 (ko) | 2002-10-04 | 2012-04-12 | 프라나 바이오테크놀로지 리미티드 | 신경 활성 화합물 |
| WO2004056318A2 (en) * | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
| RS50891B (sr) | 2003-02-13 | 2010-08-31 | Octapharma Ag. | Postupak za pripremanje rastvora albumina |
| WO2005065069A2 (en) | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| AT413336B (de) * | 2003-09-12 | 2006-02-15 | Mattner Frank Dr | Apherese-vorrichtung |
| US20050182044A1 (en) | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| RU2261702C1 (ru) * | 2004-09-23 | 2005-10-10 | Смирнов Алексей Владимирович | Способ лечения гипергомоцистеинемии у больных с хронической почечной недостаточностью, получающих лечение гемодиализом или гемофильтрацией |
| RU2281090C2 (ru) * | 2004-09-23 | 2006-08-10 | Алексей Владимирович Смирнов | Способ лечения больных хронической почечной недостаточностью |
| US7436304B1 (en) | 2005-07-19 | 2008-10-14 | Visible Assets, Inc | Evidence tracking |
-
2007
- 2007-10-26 ES ES200702831A patent/ES2332846B1/es not_active Expired - Fee Related
-
2008
- 2008-10-17 AR ARP080104523A patent/AR068901A1/es unknown
- 2008-10-17 NZ NZ572131A patent/NZ572131A/en unknown
- 2008-10-17 RU RU2008141076/15A patent/RU2414925C2/ru active
- 2008-10-22 PL PL08380301T patent/PL2111868T3/pl unknown
- 2008-10-22 EP EP08380301.5A patent/EP2111868B1/en active Active
- 2008-10-22 ES ES08380301T patent/ES2428698T3/es active Active
- 2008-10-22 PT PT83803015T patent/PT2111868E/pt unknown
- 2008-10-23 BR BRPI0804623A patent/BRPI0804623B8/pt active IP Right Grant
- 2008-10-23 CL CL2008003133A patent/CL2008003133A1/es unknown
- 2008-10-23 UY UY31418A patent/UY31418A1/es not_active Application Discontinuation
- 2008-10-23 CN CN2008101705786A patent/CN101417123B/zh active Active
- 2008-10-23 MX MX2008013635A patent/MX2008013635A/es active IP Right Grant
- 2008-10-24 JP JP2008274076A patent/JP5437619B2/ja active Active
- 2008-10-24 CA CA2641830A patent/CA2641830C/en active Active
- 2008-10-24 AU AU2008233025A patent/AU2008233025B8/en active Active
- 2008-10-24 US US12/257,814 patent/US7851446B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2802628C2 (ru) * | 2018-10-25 | 2023-08-30 | Грифольс Уорлдуайд Оперейшнс Лимитед | Использование плазмафереза малого объема для лечения болезни альцгеймера на ранних и средних стадиях |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2641830C (en) | 2013-07-16 |
| ES2428698T3 (es) | 2013-11-08 |
| AU2008233025B2 (en) | 2013-06-27 |
| UY31418A1 (es) | 2009-05-29 |
| HK1126689A1 (en) | 2009-09-11 |
| RU2008141076A (ru) | 2010-04-27 |
| CN101417123B (zh) | 2012-06-27 |
| CA2641830A1 (en) | 2009-04-26 |
| PL2111868T3 (pl) | 2014-01-31 |
| CN101417123A (zh) | 2009-04-29 |
| US20090111740A1 (en) | 2009-04-30 |
| BRPI0804623A2 (pt) | 2009-06-30 |
| BRPI0804623B1 (pt) | 2020-02-11 |
| RU2414925C2 (ru) | 2011-03-27 |
| EP2111868B1 (en) | 2013-08-21 |
| JP5437619B2 (ja) | 2014-03-12 |
| NZ572131A (en) | 2010-06-25 |
| US7851446B2 (en) | 2010-12-14 |
| AU2008233025A1 (en) | 2009-05-14 |
| ES2332846B1 (es) | 2010-07-08 |
| JP2009108059A (ja) | 2009-05-21 |
| PT2111868E (pt) | 2013-10-17 |
| AR068901A1 (es) | 2009-12-16 |
| ES2332846A1 (es) | 2010-02-12 |
| EP2111868A1 (en) | 2009-10-28 |
| AU2008233025B8 (en) | 2013-07-25 |
| BRPI0804623B8 (pt) | 2021-05-25 |
| MX2008013635A (es) | 2009-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2008003133A1 (es) | Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. | |
| Viebahn-Hänsler et al. | Ozone in medicine: the low-dose ozone concept—guidelines and treatment strategies | |
| WO2007109006A3 (en) | Infusion device capable of providing multiple liquid medicaments | |
| AR084816A1 (es) | Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer | |
| AR111572A2 (es) | Formas farmacéuticas que contienen vardenafilo | |
| AR099078A2 (es) | Un medicamento que comprende acetato de glatiramer | |
| BR0317450A (pt) | Fluidos de diálise biocompatìveis contendo icodextrinas | |
| CY1106430T1 (el) | Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο | |
| BRPI0411032A (pt) | composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica | |
| JP2013541583A5 (es) | ||
| CL2008001820A1 (es) | Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer. | |
| TW200628182A (en) | Injection device for administering a medication liquid | |
| CY1116171T1 (el) | Χρηση ακετυλο-l-καρνιτινης για την παρασκευη φαρμακου για τη θεραπευτικη αγωγη του νευροπαθητικου πονου σε διαβητικους ασθενεις | |
| TWM508308U (zh) | 滲透式薄膜貼片之改良結構 | |
| Nordal | Where has all the psychotherapy gone? | |
| CN201441679U (zh) | 走动式输液架 | |
| CN202314371U (zh) | 输液避光瓶套 | |
| Wainshtok et al. | Gardner-Diamond syndrome: A case presentation | |
| JP1781851S (ja) | 薬物供給システム | |
| Malaiyandi | Methadone overdose | |
| AR063206A1 (es) | Tratamiento del dolor | |
| Lin et al. | The Improved Process on Preparing the Examination for Transaterial Chemoembolization | |
| Kumanyika | Vital Directions in Health: Prescriptions for Our Future-APHA Past President Session | |
| TWD203321S (zh) | 輸液用泵浦之部分 | |
| Tseng | Toxic epidermal necrolysis: case report |